KUALA LUMPUR, Sept 8 -- Nippon Express Co Ltd is developing pharmaceutical supply chain networks that meet hardware and software requirements for Good Distribution Practices (GDP), thereby enabling safer, more secure pharmaceutical supplies.
In view of the globalisation of pharmaceutical supply chains, the Company will also be setting up GDP-compliant business locations in major markets worldwide to enhance its supply networks on a global level, according to a statement.
Nippon Express will also employ digital technologies of IoT and blockchain to track logistics information end-to-end, doing its part to optimise supply chains for the industry as a whole via a data-driven approach that offers traceability and increased operational efficiency.
The Company is currently setting up pharmaceutical-specific facilities in East Japan, West Japan, Kyushu and Toyama to complement the ‘medical hubs’ of Narita International Airport and Kansai International Airport.
These facilities will be equipped to handle GDP-compliant quality control and business continuity plans pertaining to pharmaceutical supply, and platforms will be constructed to allow for joint warehouse storage and transport.
Nippon Express is drawing fully on the strengths of its own global network to link up infrastructure and forwarding functions in developing overseas logistics networks that guarantee safety on a global level as required for pharmaceutical logistics.
It established a new Digital Platform Strategy Office in April to provide the pharmaceutical industry and other industries with solutions designed to fully optimise their supply chains.
In pursuit of its social mission of becoming a driving force in society's development through logistics, Nippon Express will be making full use of its global pharmaceutical supply networks to serve customers in the pharmaceutical industry and create new value via logistics.
-- BERNAMA
No comments:
Post a Comment